DWAS - ETF AI Analysis
Top Page
Invesco DWA SmallCap Momentum ETF (DWAS)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and in recent months, indicating positive momentum in its strategy.
Momentum in Top Holdings
Many of the largest positions, especially in health care and technology, have delivered strong year-to-date gains that support the fund’s overall returns.
Focused Small-Cap Growth Strategy
By targeting small-cap stocks with strong price momentum, the ETF offers exposure to a segment of the market that can outperform during favorable conditions.
Negative Factors
High Expense Ratio
The fund’s fees are relatively high for an ETF, which can eat into long-term returns compared with lower-cost alternatives.
Sector Concentration in Health Care and Technology
A large share of assets is concentrated in health care and technology, increasing the risk if these sectors experience a downturn.
Limited Geographic Diversification
The ETF is almost entirely invested in U.S. companies, offering little protection if the U.S. market struggles compared with other regions.
DWAS vs. SPDR S&P 500 ETF (SPY)
AUM409.65M
RegionNorth America
Expense Ratio0.60%
Beta1.21
IssuerInvesco
Inception DateJul 19, 2012
Dividend Yield0.12%
Asset ClassEquity
Index TrackedDorsey Wright SmallCap Tech Leaders Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume13,219
30 Day Avg. Volume12,059
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
136.29Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering201
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DWAS Summary
The Invesco DWA SmallCap Momentum ETF (DWAS) follows the Dorsey Wright SmallCap Technical Leaders Index, focusing on smaller U.S. companies whose stock prices have been rising strongly. It holds a wide mix of sectors, with a lot in health care, technology, and industrials. While its top holdings are lesser-known names, it has included recognizable tech names like SanDisk in the past. Someone might invest in DWAS to seek higher growth and diversify beyond large, well-known companies. However, small-cap momentum stocks can be very volatile and may fall quickly when market conditions change.
How much will it cost me?The Invesco DWA SmallCap Momentum ETF (DWAS) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on small-cap stocks with strong momentum, which requires more research and management compared to passively managed ETFs. It’s designed for investors seeking growth opportunities in dynamic, smaller companies.
What would affect this ETF?The DWAS ETF, focused on U.S. small-cap stocks with strong momentum, could benefit from economic growth and innovation in sectors like Health Care and Technology, which make up a significant portion of its holdings. However, it may face challenges during periods of economic uncertainty or rising interest rates, which can negatively impact small-cap companies and momentum-driven strategies. Regulatory changes or sector-specific headwinds could also influence the performance of its top holdings.
DWAS Top 10 Holdings
DWAS is leaning hard into U.S. small-cap momentum, with a clear tilt toward health care and tech names that can move fast in either direction. Biotech players like Tango Therapeutics and Kodiak Sciences have been rising sharply, giving the fund much of its recent spark, while early-stage name Erasca looks more like dead weight, with weak trends despite its high-risk promise. On the tech side, SanDisk and Planet Labs are steadily pulling their weight, helping balance out the more volatile biotech bets in this concentrated, all‑U.S. small-cap mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| SanDisk Corp | 1.89% | $7.79M | $146.11B | 3216.39% | 55 Neutral | |
| Sezzle Inc. | 1.71% | $7.05M | $2.66B | 61.33% | 80 Outperform | |
| Kodiak Sciences | 1.67% | $6.89M | $2.77B | 947.74% | 35 Underperform | |
| Tango Therapeutics | 1.60% | $6.58M | $3.68B | 1667.11% | 59 Neutral | |
| Planet Labs PBC | 1.49% | $6.12M | $12.27B | 939.59% | 57 Neutral | |
| Bel Fuse Inc | 1.47% | $6.07M | $3.45B | 267.12% | 73 Outperform | |
| Terns Pharmaceuticals | 1.42% | $5.83M | $6.10B | 1701.02% | 45 Neutral | |
| Heritage Insurance Holdings | 1.37% | $5.63M | $899.20M | 58.28% | 72 Outperform | |
| Erasca | 1.32% | $5.43M | $6.68B | 1267.86% | 34 Underperform | |
| Lumentum Holdings | 1.13% | $4.66M | $62.95B | 1330.89% | 61 Neutral |
DWAS Technical Analysis
Positive
―
Price Trends
103.06
Positive
101.62
Positive
96.17
Positive
Market Momentum
2.84
Positive
64.97
Neutral
48.86
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DWAS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 108.98, equal to the 50-day MA of 103.06, and equal to the 200-day MA of 96.17, indicating a bullish trend. The MACD of 2.84 indicates Positive momentum. The RSI at 64.97 is Neutral, neither overbought nor oversold. The STOCH value of 48.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DWAS.
DWAS Peer Comparison
Comparison Results
Performance Comparison
DWAS
Invesco DWA SmallCap Momentum ETF
112.67
34.69
44.49%
GSSC
Goldman Sachs Activebeta U.S. Small Cap Equity ETF
―
―
―
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
EES
WisdomTree U.S. SmallCap Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents